Member Info for trillsg

Ihr Schweizer seid nicht dumm. Viel Glück Freunde, es wird bald alles gut gehen, da bin ich mir sicher. Sie müssen denken, dass wir Engländer im Forum verrückt sind, und ich mache Ihnen keine Vorwürfe.

Call me a fool but just bought more.

Thanks drshan. Someone other than us wants the results quick if they're doing overtime on it.

Returning to Saturday's tweet. Does anyone know what they will be doing for us on MicrtoxBT?
Replying to
@gjbrandon

@antonannon
and 5 others
According to the Dx lab the interim datapoint samples are actually being done this weekend. The Dx lab has been inundated with Delta case loads and they are ping this on weekend overtime. We at PBM are indebted to this Dx team.

https://www.dx-labs.tech/
We at DX Labs support our clients to define their Big Data Strategy by identifying appropriate technologies and solutions in cost effective manner.(this?)
Or this? DX Labs being a leading IoT development company, our focus is on providing best IoT applications to our customers which ranges from
Or something else?

£250 UT trade last orders at 27.50p. Is that China Resource starting their hostile takeover?

https://www.chinadaily.com.cn/a/202102/26/WS60384de3a31024ad0baab35b.html
2021-02-26
Some of the largest deals last year included China Resources Group's involvement in a 4.2-billion-pound acquisition of UK waste resources management company Viridor, and Hong Kong-based Link Asset Management's 380-million-pound purchase of the 17-floor London office building The Cabot.

("MoU") with China Resources Environmental Protection Development Limited ("China Resources"), a wholly-owned subsidiary of China Resources Group

I guess Gerry will be dealing with this guy: https://www.linkedin.com/in/johnzhanggy/?originalSubdomain=cn#
China Resources Environmental Protection Technology Ltd. (the company) is the flagship company under the China Resources Group specializing in environmental protection investment business. The China Resources Group is a state-owned enterprise ranked #80 in Fortune Global 500
• Responsibilities: 1) In charge of deal sourcing on M&A/buyout opportunities, leading due diligence, negation, and deal financing processes. Deals include China mainland, Hong Kong, Singapore listed and private companies; 2) Collaborating with leading international enterprises, setting JVs and promoting business to the China Resources Group and the market at China. 3) Collaborating with leading universities and research institutions, identify and promote cutting-edge environmental protection technologies. 4) Business developing with the local government at China, acquiring opportunities on environment related business, industrial park business and real estate business. 5) Studying and identifying business opportunities on carbon neutral related industries. 6) In charge of Hong Kong and offshore business for the company

The sp should be rising as the CR deal nears completion. Has to be placees who probably never expected it to drop below their buy in price. Average down you fools!

The greed appears to be slowing. Come on lets have the bounce now.

Last month! Jesus time flies.

The latest info I'm aware of is Dr Sterghios Moschos, our partner in MicrotoxBT, tweeting "results imminent" last week I believe. RNS's basically say testing is ongoing.

MicrotoxBT is virtually 100% accurate.
https://finance.yahoo.com/news/covid-test-easy-breathing-162334378.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAEAVlOo68kjfj4M5Zu2iz6clc3Hh7C4SDsT4AXcPRMQKC0Mex0ZZBKvFu5n-IQe3qHCLh8Py2HE0hJ4-KAhJXfBYLvGAOHVPiOZ4xK-oLxEdVp5VcivLR_7xMhZkfKX3atDb6cu2NqqYI70XHK_Bgr-EvnksAc3Hn-OFS-G1RUhG

But the SpiroNose had a relatively high rate of false positives, the study found. Because of this problem, the device does not provide consumers with a definitive diagnosis; the results either come back negative or inconclusive, in which case a standard polymerase chain reaction test is administered.

.

Don't forget the 60 jobs in Cork for September Sipps. They'll have to start advertising those soon to allow successful applicants to work their notices etc. It's a heck of a lot.

Cheers Chesh, makes sense. Must be a huge task coming to an agreement on that, would explain the extension in negotiations. How do you put a value on Microtoxpd, a worlds first and best detection there is?

Meant MW and CR.

Not sure what is meant by a 'single entity' Chesh. My best guess guess is that CR and DV IPO in China and although under the umbrella of both companies is classed as a subsidiary? CR do like doing just that, 9 to date last one being in March.

Paul, nice try but September is very late Q3 unlike July which is EARLY Q3

"We expect updates from our Joint Venture agreement with China Resources and roll-out in the US to follow early in Q3."

Could be some placees set stop losses at 30p due to not having the security of warrants?

Hopefully MicrotoxPD was mentioned.
AGENDA:
The EU Sewage Sentinel System
for SARS-CoV-2 (EU4S)
Solutions and Science for Support
7th of July
https://ec.europa.eu/jrc/sites/default/files/eu4s-town_hall_v_-_final_agenda_final_final.pdf
https://ec.europa.eu/jrc/en/event/webinar/eu4s-town-hall-meeting
A series of four virtual ‘Town Hall’ events were organised over the past year in close collaboration with the World Health Organization (WHO), the UN Environment Programme (UNEP) and other national and international partners to facilitate the exchange of best practices and experiences. The platform has now reached a high level of technological readiness, enabling the screening of large population groups to identify where more detailed analysis is needed. This can ultimately help speed up the detection of variants and be a valuable part of an increased genomic and epidemiological surveillance campaign.

This fifth Town Hall Meeting, organised by the Commission in close collaboration with the stakeholders from the European water and health sector, will showcase European and international solutions in place. Participants from around the world will present business solutions, case studies, science advances and decision-support tools for the detection of SARS-CoV-2 and its variants, gathering the significant amount of information available from the ongoing national and regional studies in the EU.